Brown Brothers Harriman & CO Covetrus, Inc. Transaction History

Brown Brothers Harriman & CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$13.8 - $20.82 $4,443 - $6,704	-322 Reduced 66.67%	161 $3,000
Q3 2021 Nov 15, 2021	SELL	$18.14 - $27.03 $2,412 - $3,594	-133 Reduced 21.59%	483 $9,000
Q2 2021 Aug 13, 2021	BUY	$25.24 - $30.86 $25 - $30	1 Added 0.16%	616 $17,000
Q4 2020 Feb 16, 2021	SELL	$24.45 - $31.59 $33,252 - $42,962	-1,360 Reduced 68.86%	615 $18,000
Q3 2020 Nov 16, 2020	BUY	$17.22 - $24.59 $1,188 - $1,696	69 Added 3.62%	1,975 $48,000
Q2 2020 Aug 13, 2020	SELL	$6.46 - $19.27 $3,133 - $9,345	-485 Reduced 20.28%	1,906 $34,000
Q1 2020 May 15, 2020	SELL	$5.64 - $15.23 $10,501 - $28,358	-1,862 Reduced 43.78%	2,391 $19,000
Q4 2019 Feb 14, 2020	SELL	$8.8 - $14.93 $15,558 - $26,396	-1,768 Reduced 29.36%	4,253 $56,000
Q3 2019 Nov 14, 2019	SELL	$11.76 - $25.57 $39,478 - $85,838	-3,357 Reduced 35.8%	6,021 $72,000
Q2 2019 Aug 14, 2019	SELL	$22.88 - $33.27 $87,584 - $127,357	-3,828 Reduced 28.99%	9,378 $229,000
Q1 2019 May 15, 2019	BUY	$31.52 - $46.19 $416,253 - $609,985	13,206 New	13,206 $421,000

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.